当前位置： SCI文献检索 > TRANSPLANTATION PROCEEDINGS期刊下所有文献 > Recommendations for use of marginal donors in heart transplantation: Brazilian Association of Organs Transplantation guideline.

Recommendations for use of marginal donors in heart transplantation: Brazilian Association of Organs Transplantation guideline.

Abstract：

:The high prevalence of heart failure has increased the candidate list for heart transplantation; however, there is a shortage of viable donated organs, which is responsible for the high mortality of patients awaiting a transplantation. Because the marginal donor presents additional risk factors, it is not considered to be an ideal donor. The use of a marginal donor is only justified in situations when the risk of patient death due to heart disease is greater than that offered by the donor. These recommendations sought to expand the supply of donors, consequently increasing the transplant rate. We selected articles based on robust evidence to provide a substratum to develop recommendations for donors who exceed the traditional acceptance criteria. Recipient survival in the immediate postoperative period is intimately linked to allograft quality. Primary allograft failure is responsible for 38% to 40% of immediate deaths after heart transplantation: therefore; marginal donor selection must be more rigorous to not increase the surgical risk. The main donor risk factors with the respective evidence levels are: cancer in the donor (B), female donor (B), donor death due to hemorrhagic stroke (B), donor age above 50 years (relative risk [RR] = 1.5) (B), weight mismatch between donor and recipient < 0.8 (RR = 1.3) (B), ischemia > 240 minutes (RR = 1.2) (B), left ventricular dysfunction with ejection fraction below 45% (B), and use of high doses of vasoactive drugs (dopamine > 15 mg/kg·min) (B). Factors that impact recipient mortality are: age over 50 years (RR = 1.5); allograft harvest at a distance; adult recipient weighing more than 20% of the donor; high doses of vasoactive drugs (dopamine greater than 15 mg/kg·min) and ischemic time >4 hours. The use of a marginal donor is only justified when it is able to increase life expectancy compared with clinical treatment, albeit the outcomes are interior to those using an ideal donor.

journal_name

Transplant Proc

journal_title

Transplantation proceedings

authors

Fiorelli AI,Stolf NA,Pego-Fernandes PM,Oliveira Junior JL,Santos RH,Contreras CA,Filho DD,Dinkhuysen JJ,Moreira MC,Mejia JA,Castro MC

doi

10.1016/j.transproceed.2010.12.047

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

211-5

issue

eissn

0041-1345

issn

1873-2623

pii

S0041-1345(10)01962-7

journal_volume

pub_type

杂志文章

在线工具

Recommendations for use of marginal donors in heart transplantation: Brazilian Association of Organs Transplantation guideline.